Arne Gruen

Humboldt-Universität zu Berlin

Papers

1

Total Citations

4

H-Index

1

About

Dr. Arne Gruen is a leading expert in the application of advanced molecular imaging to precision radiation oncology, with a primary focus on prostate cancer. His research centers on harnessing the power of PSMA PET-CT and MRI to detect and treat locally recurrent prostate cancer with unprecedented accuracy. Dr. Gruen’s major contribution lies in demonstrating that PSMA PET-based detection of circumscribed local recurrences can be effectively targeted with stereotactic body radiotherapy (SBRT), offering a highly precise salvage treatment option for patients who have failed definitive first-line therapy. This work, detailed in his 2023 publication, has quickly garnered attention with 4 citations, establishing a new paradigm for managing biochemical recurrence. By integrating cutting-edge imaging with advanced radiotherapy techniques, Dr. Gruen is helping to minimize treatment toxicity while maximizing tumor control. His research is instrumental in moving the field toward truly personalized, image-guided salvage therapy, significantly impacting clinical decision-making for men facing recurrent prostate cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
PSMA PET‐based stereotactic body radiotherapy for locally recurrent prostate cancer after definitive first‐line therapy
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Humboldt-Universität zu Berlin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago